Brooks Rahmer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Investor Relations Contact | - | - |
Career history of Brooks Rahmer
Former positions of Brooks Rahmer
| Companies | Position | Start | End |
|---|---|---|---|
| MYOKARDIA, INC. | Investor Relations Contact | 01/05/2019 | 01/01/2021 |
Statistics
International
| United States | 3 |
Operational
| Investor Relations Contact | 2 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Brooks Rahmer
- Experience
